نمایش پرونده ساده آیتم

dc.contributor.authorFazeli-Bakhtiyari, R
dc.contributor.authorSorouraddin, MH
dc.contributor.authorFarajzadeh, MA
dc.contributor.authorJouyban, A
dc.date.accessioned2018-08-26T07:45:19Z
dc.date.available2018-08-26T07:45:19Z
dc.date.issued2015
dc.identifier10.4155/bio.14.175
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/48336
dc.description.abstractBackground: A new capillary zone electrophoresis (CZE) with ultraviolet detection method has been developed and validated for the analysis of four antiarrhythmic drugs in human plasma samples. Methods: In this study, a dispersive liquid-liquid microextraction (DLLME) coupled with field-amplified sample stacking (FASS) was employed for biological samples clean-up and sensitivity enhancement in CZE. Results: Under optimum DLLME-FASS-CZE conditions, enhancement factors were in the range of 157-314. The method was validated over the concentration range of 20-800 ng/ml in human plasma. Inter- and intra-day precision and the accuracy were less than 20%; the detection limits ranged from 2.5 to 4.7 ng/ml. Furthermore, the validated method was successfully applied to the detection of studied drugs in patients' plasma samples.
dc.language.isoEnglish
dc.relation.ispartofBIOANALYSIS
dc.titleDetection limit enhancement of antiarrhythmic drugs in human plasma using capillary electrophoresis with dispersive liquid-liquid microextraction and field-amplified sample stacking method
dc.typeArticle
dc.citation.volume7
dc.citation.issue1
dc.citation.spage21
dc.citation.epage37
dc.citation.indexWeb of science


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم